Premier Partners

Investment decisions rest with the twelve named partners, who average 19 years of investment experience and collectively own the firm. The firm operates without external shareholders, so partner-level deliberations — conducted through the member assembly — are the sole decision-making body. Day-to-day investment activities are split across three divisions: PE, VC, and Bio/Healthcare.

The firm's proprietary deal flow draws on the partners' deep operational backgrounds across Korean conglomerates in electronics, telecom, automotive, securities, and medical devices. Each partner maintains sector-specific networks, and the firm's mid-market focus — combined with a 20-year track record — places it early in auction processes for domestic companies. The firm does not operate a formal club-deal network but relies on repeat relationships with Korean institutional LPs.

The firm invests from seed and early-stage venture through growth capital and buyouts. Its portfolio spans venture-stage technology and healthcare companies alongside mature industrials acquired through control buyouts. In buyout situations, the firm frequently embeds its own operating partners into the portfolio company to drive post-acquisition value creation.

The firm's published ESG policy explicitly rules out investments in controversial weapons, civilian firearms, alcohol, tobacco, gambling, and coal-fired power-plant construction. It also screens out companies linked to human-rights violations or severe environmental damage. These exclusions are enforced at the investment-review stage by an internal ESG committee and disclosed to LPs annually.

Premier Partners has no parent company, no operating-company sponsor, and no family-office capital. It is an independent, partner-owned firm that has raised 12 blind venture funds and seven private-equity vehicles from Korean and international institutional limited partners since 2005.